Table 3.
Concentration of lipid, apoAI, apoB and lipid and lipoprotein ratios in the control group, patients ≤ 50 years of age and > 50 years of age, and in subgroup patients with oldest age and the largest the CAP lesion size and in all patients, the median (min- max)
| Control group | Patients ≤ 50 years of age | Patients >50 years of age | Oldest patients with the largest sCAP | All patients | |
|---|---|---|---|---|---|
| n = 20 | n = 20 | n = 23 | n = 15 | n = 43 | |
| TG (mmol/L) | 1.07(0.70–1.94) | 1.27(0.65–3.37) | 1.45(0.58–4.26) | 1.34(0.58–4.26) | 1.33(0.58–4.26) |
| TC (mmol/L) | 4.92(4.35–5.69) | 5.12(4.06–7.20) | 5.51(3.80-7.40) | 5.43(4.25–7.40) | 5.38(3.80–7.40) |
| LDL-C (mmol/L) | 3.15(2.20–3.62) | 3.60(2.36–5.20) | 4.06(2.14–5.23) | 3.85(2.69–4.71) | 3.78(2.14–5.23) |
| HDL-C (mmol/L) | 1.42(1.13–2.40) | 1.37(0.62–2.07) | 1.13(0.49–1.99) | 1.08(0.49–1.86) | 1.16(0.49–2.07) |
| nHDL-C (mmol/L) | 3.62(2.53–4.19) | 3.85(2.66–5.82) | 4.29(2.64–6.21) | 4.06(3.15–6.11) | 3.93(2.64–6.21) |
| apoAI (mg/L) | 1680(1500–2030) | 1500(790–2350) | 1440(950–1820) | 1420(1050–1820) | 1440(790–2350) |
| apoB (mg/L) | 880(620–1060) | 760(520–1340) | 970(500–1490) | 800(500–1490) | 870(500–1490) |
| TC/HDL-C | 3.45(2.17–4.45) | 3.67(2.56–6.00) | 4.82(2.69–9.0)* | 5.01(2.69–9.27)* | 4.63(2.56–9.27) |
| LDL/HDL-C | 2.22(1.11–3.72) | 2.62(1.35–6.53) | 3.57(1.97–9.53)* | 3.52(1.54–6.31)* | 3.24(1.35–9.53) |
| TG/HDL-C | 1.78(1.0–3.2) | 2.13(0.97–8.28) | 2.83(0.72–11.8)* | 2.83(0.72–7.54)* | 2.56(0.72–11.8) |
| HDL-C/apoAI | 0.33(0.32–0.47) | 0.35(0.23–0.66) | 0.30(0.16–0.50) | 0.29(0.0.16–0.48) | 0.31(0.16–0.66) |
| apoAI/apoB | 1.89(1.17–3.27) | 1.82(1.17–3.17) | 1.49(0.70–2.55)* | 1.77(0.80–2.45) | 1.65(0.70–3.17) |
p < 0.05-*; sCAP - the size of chronic apical periodontitis lesion